Stunned, infarcted, and normal myocardium in dogs: Simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast

Radiology

Volumn 226, Issue 3, 2003, Pages 723-730

  Weiss, Clifford R ^a   Aletras, Anthony H ^a   London, James F ^a   Taylor, Joni L ^a   Epstein, Frederick H ^a   Wassmuth, Ralf ^a   Balaban, Robert S ^a   Arai, Andrew E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Animals; Experimental study; Heart, experimental studies; Magnetic resonance (MR), magnetization transfer contrast; Myocardium, infarction, 511.77; Myocardium, MR

Indexed keywords

GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLAND ALTMAN ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL MOTION; LINEAR REGRESSION ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STUNNED HEART MUSCLE;

ANIMALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DOGS; GADOLINIUM DTPA; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; MYOCARDIUM;

EID: 0037372879     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2263012196     Document Type: Article

References (31)

1. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-770.
2. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999; 100: 1697-1702.
3. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31:1040-1048.
4. Baer FM, Theissen P, Crnac J, et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000; 21:981-991.
5. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-223.
6. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992-2002.
7. Mathews VP, Ulmer JL, White ML, Hamilton CA, Reboussen DM, Elster AD. Depiction of intracranial vessels with MRA: utility of magnetization transfer saturation and gadolinium. J Comput Assist Tomogr 1999; 23:597-602.
8. Tanttu JI, Sepponen RE, Lipton MJ, Kuusela T. Synergistic enhancement of MRI with Gd-DTPA and magnetization transfer. J Comput Assist Tomogr 1992; 16:19-24.
9. Balaban RS, Chesnick S, Hedges K, Samaha F, Heineman FW. Magnetization transfer contrast in MR imaging of the heart. Radiology 1991; 180:671-675.
10. Feinstein JA, Epstein FH, Arai AE, et al. Using cardiac phase to order reconstruction (CAPTOR): a method to improve diastolic images. J Magn Reson Imaging 1997; 7:794-798.
11. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104:2838-2842.
12. Epstein FH, Wolff SD, Arai AE. Segmented k-space fast cardiac imaging using an echo-train readout. Magn Reson Med 1999; 41:609-613.
13. Epstein FH, Arai AE. Optimization of fast cardiac imaging using an echo-train read-out. J Magn Reson Imaging 2000; 11:75-80.
14. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101:593-600.
15. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995; 92:1902-1910.
16. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94:3318-3326.
17. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echoplanar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999; 211:698-708.
18. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997; 30:1086-1094.
19. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999; 99:690-696.
20. Holman ER, van Jonbergen HP, van Dijkman PR, van der Laarse A, de Roos A, van der Wall EE. Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol 1993; 71:1036-1040.
21. van der Wall EE, van Dijkman PR, de Roos A, et al. Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: its potential in assessing reperfusion. Br Heart J 1990; 63:12-17.
22. Holman ER, van Rossum AC, Doesburg T, van der Wall EE, de Roos A, Visser CA. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA. Magn Reson Imaging 1996; 14:21-29.
23. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
24. de Roos A, Matheijssen NA, Doornbos J, van Dijkman PR, van Voorthuisen AE, van der Wall EE. Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology 1990; 176:517-521.
25. Rogers WJ Jr, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999; 99:744-750.
26. Dendale P, Franken PR, Block P, Pratikakis Y, de Roos A. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998; 135(5 pt 1):875-880.
27. Masui T, Saeed M, Wendland MF, Higgins CB. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA. Radiology 1991; 181:77-83.
28. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996; 36:684-693.
29. Saeed M, Wendland MF, Takehara Y, Masui T, Higgins CB. Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology 1992; 182:675-683.
30. Scholz TD, Hoyt RF, DeLeonardis JR, Ceckler TL, Balaban RS. Water-macromolecular proton magnetization transfer in infarcted myocardium: a method to enhance magnetic resonance image contrast. Magn Reson Med 1995; 33:178-184.
31. Muthupillai R, Dixon WT, Wilson JM, Pereyra M, Pettigrew RI, Flamm SD. Simultaneous detection and functional assessment of reperfused acute myocardial infarction with spin-lock preparation and Gd-DTPA enhancement (abstr). Proceedings of the Eighth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2000; 217.